Esophageal cancer surgery has lasting effects on QoL

Share this article:
Esophageal Cancer Surgery Has Lasting Effects on QoL
Esophageal Cancer Surgery Has Lasting Effects on QoL

(HealthDay News) -- Long-term survivors of esophageal cancer surgery who experience postoperative complications continue to experience long-lasting adverse effects on their health-related quality of life (HRQL), according to a study published online April 2 in the Journal of Clinical Oncology.

To assess the impact of postoperative complications on HRQL, Maryam Derogar, of the Karolinska Institutet in Stockholm, and colleagues utilized data from the Swedish Esophageal and Cardia Cancer register to identify 153 patients who had survived for at least five years following esophageal cancer surgery. HRQL was assessed using validated questionnaires.

The researchers found that 141 patients completed the five-year HRQL survey. Of these, 33 percent sustained a major postoperative complication, which was associated with significantly worse scores for dyspnea, fatigue, and eating restrictions compared with those who did not sustain a major postoperative complication. Sleep difficulties and gastroesophageal reflux worsened during follow-up, while the number of patients with a postoperative complication who had problems with choking decreased.

"In this population-based prospective study of five-year survivors of esophageal cancer surgery, the occurrence of major postoperative complications was found to be an independent predictor for several parameters of poor HRQL," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Home

Added corticosteroid not effective for cancer pain

Added corticosteroid not effective for cancer pain

In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.

New care guidelines issued for prostate cancer survivors

New care guidelines issued for prostate cancer survivors

New guidelines have been developed for clinical follow-up care for prostate cancer survivors. Issues addressed include health promotion, surveillance for recurrence, and new primaries.

ASCO: Goserelin helps preserve ovarian function in early breast cancer

ASCO: Goserelin helps preserve ovarian function in early ...

For premenopausal women with hormone receptor-negative early breast cancer treated with chemotherapy, goserelin can preserve ovarian function, according to a study presented at the annual ASCO meeting.